Showing results (441-450 of 1,188) with videos related to
Sort By:
Pageof 119
Cancer|February 25, 2003
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndromeJorge Cortes, Hagop Kantarjian, Maher Albitar, et al.Cancer|March 11, 2003
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromesApostolia Tsimberidou, Elihu Estey, Jorge Cortes, et al.Blood|June 21, 2008
A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndromeStefan Faderl, Farhad Ravandi, Xuelin Huang, et al.The Journal of Thoracic and Cardiovascular Surgery|October 1, 2004
Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic siteElena Rabkin-Aikawa, Masanori Aikawa, Mark Farber, et al.Cancer|August 20, 2009
The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.Journal of Cataract and Refractive Surgery|December 26, 2015
Combined small-incision lenticule extraction and intrastromal corneal collagen crosslinking to treat mild keratoconus: Long-term follow-upEnrique O Graue-Hernandez, Gabriela L Pagano, Guillermo Garcia-De la Rosa, et al.Cancer|July 29, 2009
Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosisSergej Konoplev, Xuelin Huang, Harry A Drabkin, et al.Journal of Hematopathology|August 12, 2009
Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemiaDongjiu Ye, Guillermo Garcia-Manero, Hagop M Kantarjian, et al.Haematologica|August 10, 2012
Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignanciesGautam Borthakur, Michael G Rosenblum, Moshe Talpaz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylateJorge Cortes, Moshe Talpaz, Susan O'Brien, et al.Pageof 119